検索結果

学会发表 | 研究与开发 | 千寿制药株式会社

Denver, Colorado, United States of America Development of stable PACAP analogs as novel therapeutic agents for dry eye disease 石本理子、町田慎之介、吉松歩美、岸本矢誉衣、中嶋毅 ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, C...

nding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED). (1) Hayreh SS, and Zimmerman MB. Central retinal...

Quality Policies | About Senju | SENJU Pharmaceutical

products" that meet the needs of patients and customers, as well as requirements by regulatory agencies. Quality Policies We always pay close attention to the quality of our products to provide c...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

with the law but will operate under a high standard of ethical values so as to conduct business management that is in line with the management philosophy of SENJU in order to develop and supply pharm...

アジマイシン点眼液0.1%

TD2.7.6.4） 9） 社内資料：国内第Ⅲ相試験 （3-02） （承認年月日：2019年 6 月 18日、CTD2.7.6.5） 10） Retsema J, et al.：Antimicrob Agents Chemother, 1987； 31：1939-1947 11） 社内資料：国内第Ⅲ相試験 （3-05） （承認年月日：2019年 6 月 18日、CTD2.7.6.6） 12） 新井...